The Core Dispute

Social media influencer Revant Himatsingka, aka Food Pharmer, publicly challenged Dabur’s claim that its Chyawanprash “protects lungs from air pollution, especially PM 2.5.” Dabur ran ads in the Delhi Metro during severe smog, claiming that two spoons daily “scientifically protect” the lungs. Himatsingka highlighted major issues:

• Animal Study, Not Human: Researchers tested the product on rats, so the results cannot reliably apply to humans.
• Conflict of Interest: Three authors worked for Dabur, and the fourth worked for the Dabur Research Foundation, creating potential bias.
• High Sugar Content: Chyawanprash contains nearly 60% sugar (listed as “sharkara”), which may harm people with respiratory issues or diabetes.

The Challenge

Food Pharmer invited Dabur to a public debate, proposing doctors and nutritionists as judges. He wants to expose misleading marketing and put public health above profit.

Dabur’s Response

Amit Garg, Dabur’s Head of Marketing for Healthcare, defended the product, saying antioxidants in Amla and Shatavari help manage inflammation and fight infections. He emphasised that Chyawanprash supplements the diet but does not replace masks or other protective measures.

Industry and Regulatory Context

The Advertising Standards Council of India (ASCI) will likely review the claims. ASCI has previously asked Dabur to modify or withdraw ads with questionable health claims, including COVID protection claims. The debate highlights how brands increasingly use anti-pollution marketing in Delhi, which risks giving the public a false sense of security.

Source: NDTV